Tourmaline Bio looks to raise cash through a public offering
https://seekingalpha.com/news/4058138-tourmaline-bio-looks-to-raise-cash-through-a-public-offering?source=feed_sector_healthcare
Jan 24, 2024 - Tourmaline Bio announces proposed public offering of common stock. Underwriters may purchase additional shares.
0
Annovis Bio, Kura Oncology among other healthcare movers
https://seekingalpha.com/news/4057908-annovis-bio-kura-oncology-among-other-healthcare-movers?source=feed_sector_healthcare
Jan 24, 2024 - Read about the top gainers and losers in the healthcare sector.
0
Adicet Bio announces pricing of public offering
https://seekingalpha.com/news/4057425-adicet-bio-announces-pricing-of-public-offering?source=feed_sector_healthcare
Jan 23, 2024 - Adicet Bio announces the pricing of its public offering, with expected gross proceeds of $85.2M, to close on January 25, 2024.
0
Adicet Bio stock sinks on proposed public offering
https://seekingalpha.com/news/4057105-adicet-bio-stock-sinks-on-proposed-public-offering?source=feed_sector_healthcare
Jan 22, 2024 - Adicet Bio starts underwritten public offering, causing its stock to plummet by 15.3%.
0
Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why
https://www.zacks.com/stock/news/2212223/sana-bio-sana-stock-rallies-105-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2212223
Jan 18, 2024 - Sana Bio (SANA) rallies 105% after the company reports encouraging pipeline progress with its candidates, SC291 and SC262, for oncology and autoimmune indications.
0
Instil Bio hits four-month high on rising volumes
https://seekingalpha.com/news/4055774-instil-bio-stock-hits-four-month-high?source=feed_sector_healthcare
Jan 17, 2024 - Instil Bio (TIL) stock surged 21% on Wednesday after the biotech announced cost-cutting measures and a new partnership for its ITIL-306 program. Read more here.
0
IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why
https://www.zacks.com/stock/news/2210645/igm-bio-igms-stock-rallies-142-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2210645
Jan 16, 2024 - IGM Bio (IGMS) stock surges 142% in the past three months on strategic reprioritization efforts to focus its resources on the development of pipeline candidates for cancer and autoimmune indications.
0
All You Need to Know About 2seventy bio, Inc. (TSVT) Rating Upgrade to Strong Buy
https://www.zacks.com/stock/news/2209668/all-you-need-to-know-about-2seventy-bio-inc-tsvt-rating-upgrade-to-strong-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2209668
Jan 12, 2024 - 2seventy bio, Inc. (TSVT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
0
Down -11.17% in 4 Weeks, Here's Why Theravance Bio (TBPH) Looks Ripe for a Turnaround
https://www.zacks.com/stock/news/2209477/down-11-17-in-4-weeks-here-s-why-theravance-bio-tbph-looks-ripe-for-a-turnaround?cid=CS-ZC-FT-tale_of_the_tape|rsi-2209477
Jan 12, 2024 - The heavy selling pressure might have exhausted for Theravance Bio (TBPH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
0
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
https://www.zacks.com/stock/news/2207689/are-medical-stocks-lagging-adicet-bio-acet-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2207689
Jan 09, 2024 - Here is how Adicet Bio, Inc. (ACET) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year.
0